Masimo's LiDCO module wins CE mark for hemodynamic monitoring
Masimo today announced it received CE mark approval for its LiDCO board-in-cable (BIC) module in hemodynamic monitoring.
Stay updated with breaking news from Masimo Root. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Masimo today announced it received CE mark approval for its LiDCO board-in-cable (BIC) module in hemodynamic monitoring.
Masimo NASDAQ MASI today announced the CE mark under the European Union Medical Device Regulation for the LiDCO boardincable BIC module.
30.11.2022 - Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized, controlled trial published in the Journal of the College of Physicians and Surgeons Pakistan. In the study, Dr. Sukriye Akdag and colleagues at Marmara ... Seite 1
Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Anesthesia & Analgesia in which Dr. Claudia Spies and colleagues investigated the relationship between parameters derived from electroencephalogram (EEG) spectra, measured using Masimo SedLine® Brain Function Monitoring, and postoperative delirium (POD) in older patients undergoing elective surgery.
May 11, 2021 healthcaretechnology Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesia & Clinical Research in which Dr. Debdipta Das and colleagues at Medical College Kolkata in India evaluated the utility of Masimo O3® Regional Oximetry to aid in monitoring septic shock patients admitted to the ICU.1 O3, available on the Masimo Root® Patient Monitoring and Connectivity Platform, uses noninvasive near-inf...